This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Quan, H.
Right arrow Articles by Jiang, Y.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Quan, H.
Right arrow Articles by Jiang, Y.-Y.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, March 2006, p. 1096-1099, Vol. 50, No. 3
0066-4804/06/$08.00+0     doi:10.1128/AAC.50.3.1096-1099.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Potent In Vitro Synergism of Fluconazole and Berberine Chloride against Clinical Isolates of Candida albicans Resistant to Fluconazole

Hua Quan,1 Ying-Ying Cao,2 Zheng Xu,1 Jing-Xia Zhao,3 Ping-Hui Gao,1 Xiao-Feng Qin,4 and Yuan-Ying Jiang1*

Department of Pharmacology, School of Pharmacy, Second Military Medical University,1 Department of Biochemical Pharmacy, School of Pharmacy, Second Military Medical University,2 Department of Organic Chemistry, School of Pharmacy, Second Military Medical University,3 Department of Dermatology, Changhai Hospital of Second Military Medical University, Shanghai 200433, People's Republic of China4

Received 21 August 2005/ Returned for modification 1 October 2005/ Accepted 11 December 2005

In vitro interaction of fluconazole and berberine chloride was investigated against 40 fluconazole-resistant clinical isolates of Candida albicans. Synergism in fungistatic activity was found with the checkerboard microdilution assay. The findings of agar diffusion tests and time-kill curves confirmed the synergistic interaction, but no antagonistic action was observed.


* Corresponding author. Mailing address: 325 Guo He Road, Shanghai 200433, People's Republic of China. Phone: 86-21-2507-0371. Fax: 86-21-6549-0641. E-mail: jiangyy{at}smmu.edu.cn.


Antimicrobial Agents and Chemotherapy, March 2006, p. 1096-1099, Vol. 50, No. 3
0066-4804/06/$08.00+0     doi:10.1128/AAC.50.3.1096-1099.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Yan, L., Li, M., Cao, Y., Gao, P., Cao, Y., Wang, Y., Jiang, Y. (2009). The alternative oxidase of Candida albicans causes reduced fluconazole susceptibility. J Antimicrob Chemother 64: 764-773 [Abstract] [Full Text]  
  • Guo, N., Liu, J., Wu, X., Bi, X., Meng, R., Wang, X., Xiang, H., Deng, X., Yu, L. (2009). Antifungal activity of thymol against clinical isolates of fluconazole-sensitive and -resistant Candida albicans. J Med Microbiol 58: 1074-1079 [Abstract] [Full Text]  
  • Guo, Q., Sun, S., Yu, J., Li, Y., Cao, L. (2008). Synergistic activity of azoles with amiodarone against clinically resistant Candida albicans tested by chequerboard and time-kill methods. J Med Microbiol 57: 457-462 [Abstract] [Full Text]  
  • Li, Y., Sun, S., Guo, Q., Ma, L., Shi, C., Su, L., Li, H. (2008). In vitro interaction between azoles and cyclosporin A against clinical isolates of Candida albicans determined by the chequerboard method and time-kill curves. J Antimicrob Chemother 61: 577-585 [Abstract] [Full Text]  
  • Merisko-Liversidge, E. M., Liversidge, G. G. (2008). Drug Nanoparticles: Formulating Poorly Water-Soluble Compounds. Toxicol Pathol 36: 43-48 [Abstract] [Full Text]